Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMRN | CTMX | URGN | ||
| Company | Amarin Corp ADR | Cytomx Thera | Urogen Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.8500 | 3.25 | 14.06 | ||
| High | 0.8700 | 5.85 | 14.70 | ||
| Low | 0.8110 | 2.78 | 13.89 | ||
| Last | 0.8393 | 5.13 | 14.40 | ||
| Change | -0.0816 | +3.50 | +0.58 | ||
| % Change | -8.86% | +214.72% | +4.20% | ||
| Volume | 3,580,900 | 206,720,313 | 179,800 | ||
| 20-Day Average Volume | 996,160 | 10,819,035 | 301,655 | ||
| Previous Close | 0.9209 | 1.63 | 13.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9360 | 2.01 | 14.01 | ||
| 20-Day Raw Stochastic | 9.46% | 83.14% | 64.86% | ||
| 20-Day Relative Strength | 41.32% | 86.10% | 47.80% | ||
| Weighted Alpha | -49.24 | -23.39 | -34.37 | ||
| Today's Opinion | 72% Sell | 80% Buy | 40% Sell | ||
| Previous Opinion | 56% Sell | 24% Buy | 40% Sell | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.47% since 04/24/24 | +214.72% since 04/24/24 | +1.34% since 04/24/24 | ||
| Low | 0.8110 on 05/01/24 | 1.58 on 04/29/24 | 13.69 on 04/26/24 | ||
| High | 0.9289 on 04/30/24 | 5.85 on 05/01/24 | 14.70 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | -4.84% since 04/01/24 | +138.60% since 04/01/24 | +1.41% since 04/01/24 | ||
| Low | 0.8110 on 05/01/24 | 1.58 on 04/29/24 | 12.37 on 04/11/24 | ||
| High | 1.1100 on 04/09/24 | 5.85 on 05/01/24 | 15.50 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | -30.64% since 02/01/24 | +235.29% since 02/01/24 | -9.43% since 02/01/24 | ||
| Low | 0.8015 on 03/14/24 | 1.38 on 02/13/24 | 12.37 on 04/11/24 | ||
| High | 1.3600 on 02/27/24 | 5.85 on 05/01/24 | 19.87 on 02/16/24 | ||
| 6-Month | |||||
| %Chg | +20.21% since 11/01/23 | +375.00% since 11/01/23 | +26.76% since 11/01/23 | ||
| Low | 0.6569 on 11/02/23 | 1.09 on 11/02/23 | 10.92 on 11/15/23 | ||
| High | 1.3700 on 01/30/24 | 5.85 on 05/01/24 | 19.87 on 02/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 344,677 | 347,465 | 337,738 | ||
| Shares Outstanding, K | 410,672 | 67,732 | 23,454 | ||
| Annual Sales | 306,910,000 | 101,210,000 | 82,710,000 | ||
| Annual Net Income | -59,110,000 | -570,000 | -102,240,000 | ||
| Last Quarter Sales | 74,710,000 | 26,610,000 | 23,530,000 | ||
| Last Quarter Net Income | -5,780,000 | 840,000 | -26,020,000 | ||
| 60-Month Beta | 1.95 | 1.09 | 1.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 02/29/24 | 0.01 on 03/11/24 | -0.72 on 03/14/24 | ||
| Latest Earnings Date | 05/01/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||